DATASHEET
Host:
Rabbit
Target Protein:
E2F1 Ser375
Modification Site:
Ser375
Clonality:
Polyclonal
Isotype:
IgG
Source:
KLH conjugated synthetic phosphopeptide derived from human E2F1 around the phosphorylation site of Ser375
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Background:
E2F's are DNA binding proteins, which associate with negative regulators, such as the retinoblastoma p107 protein, resulting in an altered rate of gene transcription. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein and another 2 members, E2F2 and E2F3, have an additional cyclin binding domain. E2F1 is proposed to be involved in several cellular processes that range from tumor suppressor, cell progression and oncogenesis. E2F1 overexpression can also drive cells into apoptosis.
VALIDATION IMAGES
Lane 1: Human Siha cell lysates; Lane 2: Human Hela cell lysates probed with E2F1 (Ser375) Polyclonal Antibody, Unconjugated (bs-10012R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: Human Hela cell lysates; Lane 2: Human MOLT-4 cell lysates probed with E2F1 Polyclonal Antibody, Unconjugated (bs-10012R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.